CONSIDERATIONS TO KNOW ABOUT AZELAPRAG FDA APPROVAL

- "Tolvaptan is accepted for ADPKD remedy, but its use is limited by various adverse results, leaving an unmet clinical want for Secure and effective therapy.Potent cytochrome P450 3A4 and/or P-glycoprotein inhibitors may well warrant AMG 986 dose reduction and may be coadministered with caution in clients with coronary heart failure handled with A